Gama Paul
CEO- Health Care
Gama Paul has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Oct 6, 2026.
On the most recent filing, Gama Paul is listed as CEO- Health Care at PROCTER & GAMBLE Co. Inside the rolling window, Gama Paul reported no open-market purchases and 2 open-market sales totaling $812K in PG. The largest disclosed transaction in the window is a sale of 3,396 PG shares on Aug 20, 2026, worth $488K.
Companies traded
Other insiders at PG
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$812K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Gama Paul made?
Gama Paul has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Gama Paul trade?
Gama Paul has filed SEC Form 4 disclosures for 1 company, including PG.
When was Gama Paul's most recent SEC Form 4 filing?
Gama Paul's most recent SEC Form 4 filing on Tracefour is dated Oct 6, 2026.
What is Gama Paul's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Gama Paul is listed as CEO- Health Care.
What is Gama Paul's total buy and sell value in the current window?
Inside the rolling retention window, Gama Paul bought $0 and sold $812K based on SEC Form 4 filings.
What was Gama Paul's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,396 PG shares on 2026-08-20, worth $488K, per SEC Form 4 filings.